Takehisa Dewa Selected Research

tetraethylenepentamine

1/2016	Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow.
1/2013	Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takehisa Dewa Research Topics

Disease

10	Neoplasms (Cancer) 01/2019 - 01/2011
5	Melanoma (Melanoma, Malignant) 01/2015 - 03/2011
2	Fibrosarcoma 02/2014 - 03/2011
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 06/2008 - 08/2007
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Hyperglycemia 01/2019
1	Carcinoma (Carcinomatosis) 03/2011
1	Rupture 06/2006

Drug/Important Bio-Agent (IBA)

9	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2011
7	Triethylenephosphoramide (TEPA)IBA 01/2016 - 01/2011
6	Liposomes (Liposome)IBA 01/2019 - 03/2011
4	Peptides (Polypeptides)IBA 01/2016 - 01/2011
4	alanyl-prolyl-arginyl-prolyl-glycineIBA 01/2016 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2013
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2014 - 06/2012
3	LuciferasesIBA 02/2014 - 03/2011
3	CholesterolIBA 01/2013 - 03/2011
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2014
2	tetraethylenepentamineIBA 01/2016 - 01/2013
2	TOR Serine-Threonine KinasesIBA 01/2015 - 01/2011
2	GoldIBA 06/2008 - 08/2007
1	MorpholinosIBA 01/2019
1	DEET (DET)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	dioleoyl phosphateIBA 01/2019
1	diethylenetriamineIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2015
1	Therapeutic UsesIBA 05/2014
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 02/2014
1	enhanced green fluorescent proteinIBA 02/2014
1	arginyl-glycyl-aspartic acidIBA 01/2013
1	dicetylphosphateIBA 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	cyclic arginine-glycine-aspartic acid peptideIBA 06/2012
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 06/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2011
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2011
1	Carboxylic AcidsIBA 08/2007
1	Glycerol (Glycerine)FDA LinkGeneric 06/2006
1	Lipid Bilayers (Lipid Bilayer)IBA 06/2006
1	1,2- dioleoyl- sn- glycero- 3- phosphoglycerol (DOPG)IBA 06/2006
1	distearoyl phosphatidylglycerol (DSPG)IBA 06/2006

Therapy/Procedure

5	Therapeutics 01/2016 - 01/2011
4	Intravenous Injections 01/2019 - 06/2012
2	Electrodes (Electrode) 06/2008 - 08/2007
1	Drug Therapy (Chemotherapy) 01/2016
1	RNAi Therapeutics 06/2012